Trial Profile
A clinical phase-II trial of neoadjuvant chemoradiation therapy using S-1 for locally advanced pancreatic cancer (PerSeUS-GP-01).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 30 Sep 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Sep 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
- 10 Aug 2009 New trial record